Axel Mescheder
Directeur Général chez Cristal Delivery BV
Profil
Axel Mescheder is currently the Chief Executive & Medical Officer at Cristal Delivery BV since 2018.
Prior to this, he worked as the Director-Research & Development at MediGene AG, Chief Medical Officer at MorphoSys AG, and Chief Medical & Development Officer at Topotarget A.
He also worked as a Research Physician at the University of Cincinnati (Ohio).
Dr. Mescheder holds a doctorate degree from the University of Kiel.
Postes actifs de Axel Mescheder
| Sociétés | Poste | Début |
|---|---|---|
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Directeur Général | 02/11/2018 |
Anciens postes connus de Axel Mescheder
| Sociétés | Poste | Fin |
|---|---|---|
| TOPOTARGET A/S | Directeur Technique/Scientifique/R&D | 31/10/2012 |
| MEDIGENE AG | Directeur Technique/Scientifique/R&D | 15/09/2008 |
| MORPHOSYS AG | Directeur Technique/Scientifique/R&D | - |
| University of Cincinnati (Ohio) | Corporate Officer/Principal | - |
Formation de Axel Mescheder
| University of Kiel | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MEDIGENE AG | Health Technology |
| MORPHOSYS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Health Technology |